Clinical Trial Update: An Observational Study on Evaluating the Efficacy and Safety of Preemptive Antiviral Therapy With Tenofovir in HBsAg-positive Patients With Diffuse Large B-cell Lymphoma Receiving Rituximab-CHOP Chemotherapy (SPEED Study)

View source ↗

Summary

An observational study sponsored by Yonsei University evaluating whether preemptive antiviral therapy with Tenofovir is effective and safe for preventing hepati…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diffuse Large B-cell Lymphoma
• Hepatitis B

Drugs mentioned

• Viread (tenofovir disoproxil fumarate)

Snippet

Sponsor: Yonsei University | Conditions: B-cell Lymphoma | Status: UNKNOWN